The Recall Desk
SevereFDA (Devices)·Z-0481-2022·Announced 2022-02-09

COVID-19 Test Kits Recalled for Unauthorized FDA Marketing and Sale

Empowered Diagnostics LLC recalled COVID-19 test kits (ImmunoPass, NAB 900-60) sold nationwide without FDA approval. Approximately 2,100 units were distributed without required marketing clearance or authorization.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This is an FDA Class I recall, the most serious regulatory classification. Although no illnesses, injuries, or deaths have been reported, Class I recalls warrant a minimum severity of 4 (Severe). The regulatory violation of marketing an unapproved diagnostic device without FDA authorization justifies the Severe rating.

Plain-English summary

Empowered Diagnostics LLC is recalling the ImmunoPass COVID-19 Neutralizing Antibody Test (NAB 900-60) across all production lots. Approximately 2,100 units of this test kit were distributed nationwide to consumers.

The test kits were offered for sale and distributed to the public without FDA marketing approval, clearance, or authorization. FDA has classified this as a Class I recall, reflecting the serious regulatory violation of distributing an unapproved medical device. Consumers cannot independently verify whether these tests provide accurate or reliable results.

Consumers who obtained these test kits should not use them. The reliability and accuracy of the test results cannot be assured because the product was not reviewed or cleared by the FDA prior to distribution. Anyone with questions should contact Empowered Diagnostics LLC or consult a healthcare provider.

The recalled product

Product
ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60
Manufacturer
Empowered Diagnostics LLC
Hazard
  • unapproved-device

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • all lots

Distribution

Distributed nationwide across the United States.